Limbtave MF 80mg/250mg Tablet
Marketer
Limbson Pharmaceuticals LLP
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Limbtave MF 80mg/250mg Tablet
Abdominal pain is effectively treated with the combined medication, StomaEase 80mg/250mg tablets. This formulation alleviates abdominal pain, bloating, discomfort, and cramping by relaxing gastrointestinal muscles and inhibiting pain-inducing chemical signals. StomaEase 80mg/250mg tablets should be taken with meals, following your doctor's prescribed dosage and duration. Dosage is individualized based on your condition and response. Complete the prescribed course; premature discontinuation may cause symptom recurrence and worsening condition. Inform your physician about all other medications you are using, as interactions are possible. Common side effects—diarrhea, nausea, vomiting, stomach upset, dry mouth, anorexia, thirst, and heartburn—are typically transient. Report any concerning side effects immediately to your doctor. Dizziness and drowsiness may occur; avoid driving or tasks requiring alertness until the effects are known. Alcohol consumption should be avoided due to increased dizziness risk. Consult your doctor regarding pregnancy, pregnancy planning, or breastfeeding before starting treatment. Kidney or liver conditions should also be disclosed to ensure appropriate dosage.
Primary Ingredients of Limbtave MF 80mg/250mg Tablet
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Limbtave MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Limbtave MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Limbtave MF 80mg/250mg Tablets. Ingest the tablets whole; do not crush, chew, or fracture them. Administer this medication with food.
Common Side effects of Limbtave MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Limbtave MF 80mg/250mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Limbtave MF 80mg/250mg Tablet with a meal.
How Limbtave MF 80mg/250mg Tablet works:
Each Limbtave MF 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic, targets abdominal smooth muscle spasms, reducing contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of pain and inflammation-causing substances in the abdomen.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Limbtave MF 80mg/250mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Limbtave MF 80mg/250mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before using this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on Limbtave MF 80mg/250mg Tablet use while breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Limbtave MF 80mg/250mg Tablets, a potential side effect of this medication, including the possibility of dizziness.
KidneyCAUTION
The medication Limbtave MF 80mg/250mg Tablet requires careful administration for individuals with kidney impairment. Dosage modification may be necessary. A physician's consultation is advised. Limbtave MF 80mg/250mg Tablet is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use 80mg/250mg Limbtave MF tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Limbtave MF 80mg/250mg Tablet :
Should you forget a dose of Limbtave MF 80mg/250mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Limbtave MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
3,018 People bought this recently